-
サマリー
あらすじ・解説
Sun Research Institute in San Antonio, Texas, is conducting a pivotal clinical trial for Cutaneous Lupus Erythematosus (CLE), a chronic autoimmune skin condition. This study aims to evaluate the safety, efficacy, and tolerability of edecesertib (formerly GS-5718), a novel oral medication. Eligible participants aged 18–75 with active CLE will receive either the investigational drug or a placebo over a 4-week period. The trial includes skin biopsies and comprehensive monitoring to assess treatment outcomes. This research is crucial for developing targeted therapies to improve quality of life for individuals affected by CLE.
https://www.sunresearch.com/cutaneous-lupus-erythematosus